Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia (Q27824808)
scientific article
Language:
Current Data About Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia
(P31) (Q13442814)
(P248)
(P698) 14726387
(P813) Sunday, November 13, 2016

(P50) (Q60394812)
(P1545) 5
(P1932) Hagop Kantarjian

(Q66380831)
(P1545) 4
(P1932) Francis Giles

(P304) 3669-76

(P407) (Q1860)

(P433) 10

(P478) 103

(P577) Saturday, May 15, 2004

(P921) (Q181600)

(Q29496)
(P887)

(Q264118)
(P887)

(P1433) (Q885070)

(P1476) "Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia" (language: en)
(P248)
(P698) 14726387
(P813) Sunday, November 13, 2016

(P2093) B Douglas Smith
(P1545) 1

Mark Levis
(P1545) 2

Miloslav Beran
(P1545) 3

Karin Berg
(P1545) 6

Kathleen M Murphy
(P1545) 7

Tianna Dauses
(P1545) 8

Jeffrey Allebach
(P1545) 9

Donald Small
(P1545) 10

other details
description scientific article

External Links
(P356) 10.1182/BLOOD-2003-11-3775
(P698) 14726387
(P3181) 3208665
(P5875) 8917834